Please assess the completion status of the following clinical trial:

Trial Title: Does Oxytocin Alter Tolerance to or Motivation for Alcohol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Heavy alcohol drinkers.~* Able to understand/complete questionnaires and procedures in English.~* Have venous access sufficient to allow blood sampling.~Exclusion Criteria:~* Latex allergy.~* Nasal condition that compromises delivery and/or absorption of intra-nasal oxytocin~* Pregnant or breast-feeding women.~* Desire to be treated for any substance use disorder or court ordered to not drink alcohol~* Medical disorders or other conditions such as alcohol withdrawal seizures or delirium tremens that may influence study outcome or participant safety.~* Positive urine drug screen for amphetamines/ methamphetamines, barbiturates, benzodiazepines, cocaine, opiates, or phencyclidine if determined by the PI to adversely affect participant safety or data integrity.~* Medications (past 30 days) that could influence participant safety or data integrity (e.g. antidepressants, antipsychotics, benzodiazepines, etc.) as determined by the PI.~* DSM 5 Disorders (other than alcohol) or current/history of neurological disease of cerebral origin, or head injury with \> 20 min loss of consciousness, if determined by the PI to affect participant safety or data integrity.~* Positive breath alcohol reading at beginning of the experimental session.~* Actively suicidal (for example, any current suicidal intent, including a plan) or are at serious suicidal risk, by clinical judgment of the PI.~* Any condition for which the PI and investigative team determine it is unsafe or not prudent to enroll a participant.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Clamp (Type: EXPERIMENTAL): Clamped alcohol exposure, repeated tests of subjective and cognitive effects of alcohol, 2 sessions (intranasal oxytocin or placebo), double blind
- Progressive work for alcohol (Type: EXPERIMENTAL): Progressive work alcohol exposure, 2 sessions (intranasal oxytocin or placebo), double blind

Based on this trial design, predict the completion outcome and termination type (if applicable).